Curio Wellness Appoints Dr. David Casarett as its New Medical Director

Curio Wellness Unveils New Leadership in Medical Direction

Curio Wellness, a pioneering cannabis company known for its commitment to health and wellness, has made significant strides in its leadership by appointing Dr. David Casarett as the Medical Director. This strategic move underscores the company's dedication to harnessing scientific approaches in developing innovative cannabis-based products.

About Curio Wellness

Founded in 2014 and based in Towson, Maryland, Curio Wellness is a cGMP-certified entity. It has established itself as a leader in the cannabis market, specially recognized for its innovative health products. By integrating scientific research with product development, Curio Wellness aims to improve the overall quality of life for its consumers.

Dr. Casarett’s Profile

Dr. David Casarett is no stranger to the world of cannabis and health innovation. Before his appointment, he served on Curio's Scientific Advisory Board, where his expertise played a pivotal role in guiding innovative approaches to cannabis-derived medicinal products. Dr. Casarett is not only a palliative care physician but also a prominent health services researcher dedicated to improving care systems for individuals facing serious illnesses.

Currently, he holds a prestigious position as a Professor of Medicine at Duke University and is the Chief of Palliative Care for Duke Health. His academic contributions include over 100 published articles in respected scientific journals and well-known platforms like Salon, Newsweek, and The New York Times. Dr. Casarett's insightful work culminated in his acclaimed book, "Stoned: A Doctor's Case for Medical Marijuana," and a TED talk that emphasizes the therapeutic benefits of cannabis.

Strategic Vision and Initiatives

In his new role, Dr. Casarett will be pivotal in various functions, including education, external communications, and spearheading scientific research and product development initiatives. His insightful leadership is expected to guide Curio's trajectory as it explores further innovations in the cannabis sector, especially concerning minor cannabinoids and their impact on health issues such as obesity and sleep disorders.

Michael Bronfein, the CEO of Curio Wellness, expressed enthusiasm over Dr. Casarett's new position, stating, "His expertise and contributions thus far have been invaluable. As he steps into this expanded role, we anticipate forging strategic partnerships that will reinforce our commitment to research and innovation."

Dr. Casarett emphasized the importance of clinical research in the cannabis space, remarking, "The scientific foundation of our product development is essential. At Curio, we strive to study cannabis thoroughly to unravel its therapeutic potential, shifting how healthcare approaches treatment strategies."

Looking Ahead

The appointment signals a new chapter for Curio Wellness as it aims to enhance its capabilities in medical product research and development. As cannabis continues to gain recognition for its potential health benefits, organizations like Curio are crucial in spearheading research-based initiatives that address both consumer needs and societal health challenges.

With this new leadership change, Curio Wellness is poised to not only remain at the forefront of the cannabis industry but also to enact significant advancements that could redefine the landscape of health and wellness.

For more insights into Curio Wellness and its innovative products, visit Curio Wellness.